Lungs & airways

Patient views needed for a Cochrane review on new drugs (mepolizumab or benralizumab) for treating exacerbations of COPD

Skills: Consumer Input, Peer Review - Consumer
Anti-IL5 therapies for chronic obstructive pulmonary disease

In this review the findings of clinical trials are examined to see whether taking the new drugs mepolizumab or benralizumab are better than a placebo for people with COPD, and reduce the number of episodes when patients' conditions seriously worsen.

Ideal Applicant

We are looking for adults with a diagnosis of COPD or their personal carers who might like to comment on this review. No previous experience is necessary.

Think you've got what it takes to get the job done for Emma?

Sign up
Log in
to respond

Questions & comments